Skip to main content
. 2023 Sep 21;389(12):1085–1095. doi: 10.1056/NEJMoa2209421

Figure 3. Heterogeneity of the Treatment Effect of Time to Recovery.

Figure 3

A hazard ratio greater than 1.0 indicates a faster time to recovery. Trial day 1 was the day receipt of trial medication or placebo began. Modified intention-to-treat data reflects an analysis of participants who underwent randomization and were enrolled within 7 days after symptom onset and received the trial drug or placebo. Shown are the covariate-adjusted and model-based estimates of the treatment effect for selected subgroups.